It’s now easier than ever to prevent TB before it develops into active disease or spreads within communities. While TB preventive treatment was once difficult to tolerate and could last 6 to 36 months, scientists have developed effective new regimens using a drug called rifapentine that last only one or three months. These breakthrough treatment course, called 1HP and 3HP, have the potential to be a key tool in ending TB worldwide — but too few people who could benefit from preventive treatment have access to it.
People at risk of developing TB — like household contacts of someone living with TB —have the #RightToPreventTB, and share the benefits of scientific progress. We are calling for an urgent scale-up of 1HP and 3HP around the world. Join our digital campaign with IMPAACT4TB and Unitaid here: https://express.adobe.com/page/pc7PYUNzuztsD/.